Biliary intraepithelial neoplasia
Citation, DOI, disclosures and article data
At the time the article was created Bruno Di Muzio had no recorded disclosures.View Bruno Di Muzio's current disclosures
At the time the article was last revised Bruno Di Muzio had no recorded disclosures.View Bruno Di Muzio's current disclosures
Before 2005, biliary atypia or biliary dysplasia were terms usually employed to refer to BilIN 5.
The incidence of BIlIN is unknown, with these lesions usually identified in the resected specimens of cholangiocarcinoma or, less commonly, elective cholecystectomies.
It has been implicated to be more frequent in chronic biliary diseases such as hepatolithiasis 2,4. Patients with primary sclerosing cholangitis have a high risk of developing BilIN 2.
The concept of BilIN as a multistep cholangiocarcinogenesis has been proposed as the biliary counterpart for the pancreatic intraepithelial neoplasia (PanIN) 1,3.
BilINs are usually not visible on gross pathology specimens, eventually characterized as a subtle granularity of the mucosa 1.
These tumors show cellular atypia in the form of micropapillary projections into the bile ducts lumen (dysplastic epithelium). They are commonly identified within the mucosa adjacent to cholangiocarcinoma 1,2. Based on the architectural atypia, they are classified as 1,5:
- grade 1 BilIN: representing the low-grade lesions
- grade 2 BilIN: representing the intermediate-grade lesions
- grade 3 BilIN: representing the high-grade lesions, therefore, carcinoma in situ
Biliary intraepithelial neoplasia is not detected on imaging.